After some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next year. | After some six years at the post, Amgen’s finance chief is telegraphing his exit from the California pharma by early next year.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Peter Griffith will be the second high-profile exec to leave Amgen this year when he retires on Sept. 1. Thomas Dittrich will…
Amgen has agreed to a $74 million settlement with investors who allege that the company hid a massive U.S. tax bill from the…
Last week’s unexpected CEO shuffle at for-profit health system Ardent Health was a “proactive, not reactive” move as the…
In her inaugural earnings call as the new CEO of Sanofi, Belén Garijo—until recently head honcho at Germany’s Merck KGaA—laid out…
In the wake of a recent safety scare in a confirmatory trial of its antibody-drug conjugate Zynlonta, ADC Therapeutics is…
Two Big Pharmas are shrinking their U.S. | AbbVie's 85 layoffs are tied to its Allergan Aesthetics headquarters in California,…
